Court Dismisses Appeal on Non-Compete Compensation Expenditure

The court dismissed the appeal filed by the assessee regarding the disallowance of Non-Compete Compensation as a business expenditure. The court held that the expenditure was capital in nature and could not be considered as revenue expenditure or allowed on a deferred basis. The decision was based on precedents and case law, including the judgment in Tecumseh India (P) Ltd. v. Addl. CIT. The court also referenced other cases such as Pitney Bowes India (P) Ltd v. CIT and Punjab Alkalies & Chemicals Ltd. v. CIT, which supported treating non-compete fees as capital expenditure.

---

---

Issues Involved:
1. Disallowance of Non-Compete Compensation as Business Expenditure.
2. Allowance of Non-Compete Compensation on Deferred Basis.

Issue-wise Detailed Analysis:

1. Disallowance of Non-Compete Compensation as Business Expenditure:

The primary issue raised by the assessee was the disallowance of Non-Compete Compensation of Rs. 4,00,00,000/- paid to National Radio & Electronics Co. Ltd (NELCO) as business expenditure. The assessee contended that the payment did not result in a capital advantage or enduring benefit and thus should be considered as revenue expenditure. However, the Assessing Officer (AO) and the Commissioner of Income Tax (Appeals) [CIT (A)] held that the expenditure was capital in nature and could not be allowed as revenue expenditure. This decision was based on the precedent set by the Special Bench of the ITAT in the case of Tecumseh India (P) Ltd. v. Addl. CIT, which held that expenditure to ward off competition is capital expenditure. Consequently, Ground No. 1 was dismissed.

2. Allowance of Non-Compete Compensation on Deferred Basis:

The assessee also raised an additional ground, arguing that if the expenditure was not allowed as a revenue expenditure, it should be allowed on a deferred basis over the term of the related agreement. The assessee cited the Chennai Bench of the ITAT in the case of Orchid Chemicals & Pharmaceuticals Ltd v. Asstt. CIT, which allowed such expenditure over a period of four years. However, the CIT (DR) countered that since the expenditure was capital in nature, it could not be amortized under section 37(1) or section 35D of the Income Tax Act. The Tribunal examined the provisions of section 37(1) and concluded that capital expenditure cannot be allowed as a deduction. The Tribunal also noted that the Special Bench judgment in Tecumseh India (P) Ltd. was binding and took precedence over the Coordinate Bench decision in Orchid Chemicals & Pharmaceuticals Ltd.

The Tribunal further analyzed the case law cited by the assessee, including the judgments of the Hon'ble Delhi High Court in Pitney Bowes India (P) Ltd v. CIT and the Hon'ble Punjab & Haryana High Court in Punjab Alkalies & Chemicals Ltd. v. CIT. These cases did not support the assessee's contention, as they upheld the treatment of non-compete fees as capital expenditure. The Tribunal also referred to the decision in Sharp Business Systems (India) Ltd. v. Dy. CIT, which held that non-compete fees, being capital in nature, could not be spread over multiple years.

In conclusion, the Tribunal held that the non-compete fee, being capital outlay, could not be allowed as revenue expenditure or deferred revenue expenditure. The additional ground raised by the assessee was dismissed, and the action of the AO was confirmed.

Judgment:

The appeal filed by the assessee was dismissed.

---